Evidence map›Paper›PMID 34043422›Full record

ArticleCirculation research2021

mInd the gAP: Intestinal Alkaline Phosphatase Puts the Breaks on Atherosclerosis.

Thomas Q de Aguiar Vallim, Elizabeth J Tarling

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Thomas Q de Aguiar VallimDepartment of Biological Chemistry (T.Q.d.A.V.), University of California Los Angeles.
Elizabeth J TarlingDepartment of Medicine (T.Q.d.A.V., E.J.T.), University of California Los Angeles.

Funding

ATP Binding Cassette Transporters in Health and DiseaseR01DK128952 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TARLING, ELIZABETH JOANNA, VALLIM, THOMAS A · 2021 to 2024
$2.4M
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver MetabolismR01DK118064 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EDWARDS, PETER A, VALLIM, THOMAS A · 2019 to 2022
$2.1M
Transcriptional control of microRNAs in lipid metabolism and atherosclerosisR01HL122677 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VALLIM, THOMAS A · 2016 to 2020
$1.9M
Post-Translational Regulation of Lipid MetabolismR01HL136543 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TARLING, ELIZABETH JOANNA · 2017 to 2021
$1.9M
Novel Post-Transcriptional Regulators of Lipid MetabolismR01DK112119 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VALLIM, THOMAS A · 2017 to 2020
$1.7M
NHLBI NIH HHS R01 HL122677NHLBI NIH HHS R01 HL136543NIDDK NIH HHS R01 DK112119NIDDK NIH HHS R01 DK118064NIDDK NIH HHS R01 DK128952
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alkaline PhosphataseAtherosclerosisHumansIntestinal MucosaAlkaline PhosphataseatherosclerosisdysbiosisEditorialsenterocyteslipopolysaccharideprevalence

Identifiers

PMID34043422
PMCPMC8171811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.